Located in Addison, Texas, ULURU is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products through the utilization of its NanoFlex Aggregate technology and OraDisc transmucosal delivery system. Yesterday, ULURU took a major step towards prominence with the announcement they have received approval from the Australian Register of Therapeutic Goods Certificate to market Altrazeal in Australia.
ULURU President and CEO Kerry P. Gray stated, “This is another important milestone in the worldwide commercialization of Altrazeal®. Strategically this is an important market as the world’s largest wound research program is currently being conducted at the Wound Management Innovation Cooperation Research Centre in Australia. This centre’s focus is the development of clinically and cost effective treatment regimens for the management of chronic wounds. Gaining the support of this influential group could have significant global implications for the marketing of Altrazeal®. It is anticipated that the initial Altrazeal® orders for Australia will occur in the next thirty days. Also, marketing approval in New Zealand is anticipated to occur in the next thirty days.”
Gray further added, “The Australian state government’s strategic initiatives in wound care are focused on cost effective clinical endpoints and patient health and wellbeing. The pharmaco-economic benefits offered by Altrazeal could enable rapid market penetration in the Australian market.”
The timing of this approval is beneficial as a major Australian wound care meeting, the Australian Wound Management Association Conference, will be held in Sydney, Australia, on March 18-21, 2012. It is anticipated that over 1,000 delegates from Australia and New Zealand will be attending this conference. The conference will enable pre-marketing launch activities to be conducted and provide maximum exposure for Altrazeal to some of the most important wound treatment healthcare professionals from both countries.
Currently, ULURU is trading in the $0.52 range. To learn more about this press release or the company as a whole, visit their corporate website at www.uluruinc.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment